Delivery Order SPE2DB22D3004-SPE2DB24FRY09
Award Date
9/24/24
Potential Completion Date
9/25/24
Potential Value
$7.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,004.24 firm fixed-price contract is for the delivery of 4566248765 ONFI 10 MG tablet, 100 count. The contract has an ultimate completion date of October 29, 2024 and was awarded on October 28, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,399.48, is for the delivery of 4567684697 ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of March 26, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567394741 ONFI 10 MG TABLET 100S, with a ceiling value of $2,008.80 and a completion date of February 27, 2025. The contract is a Firm Fixed Price (FFP) instrument, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ONFI 10 MG TABLET 100S. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $9,313.73 and a performance period extending through June 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,385.21, is for the delivery of 4,567,954,743 units of the medication ONFI 10 MG TABLET 100S. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 18, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ONFI 10 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $8,510.23 and a completion date of May 22, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,374.45, is for the delivery of ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of April 24, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract, valued at $1,928.75, is for the supply of 4565379491 - ONFI 10 MG TABLET 100S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of August 8, 2024. This award is not associated with a set-aside program. Amerisourcebergen has been awarded numerous...
This is a delivery order award to AmerisourceBergen Drug Corp for the supply of 4,565,230 units of ONFI 10 MG TABLET 100S, a pharmaceutical product, for a ceiling value of $12,087.44. The order was issued under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,707.35 firm-fixed-price contract is for the supply of ONFI 10 MG TABLET 100S, a prescription medication. The contract has an ultimate completion date of August 20, 2024. Amerisourcebergen has been awarded numerous indefinite delivery contracts (IDCs) by DLA and other federal agencies, valued up to $999,999,999, to...